Endoscopic full-thickness plication for the treatment of GERD: Five-year long-term multicenter results

Surgical Endoscopy and Other Interventional Techniques

Volumn 22, Issue 2, 2008, Pages 326-332

  Pleskow, Douglas ^a   Rothstein, Richard ^b   Kozarek, Richard ^c   Haber, Gregory ^d   Gostout, Christopher ^e   Lo, Simon ^f   Hawes, Robert ^g   Lembo, Anthony ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

^d LENOX HILL HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Endoluminal antireflux surgery; Gastroesophageal reflux disease

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; ANTIREFLUX OPERATION; ARTICLE; CARDIA; CLINICAL ARTICLE; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SAFETY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 39149099803     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-007-9667-0     Document Type: Article

References (24)

1. Nebel et al. (1976) Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 21(11):953-956
2. Locke et al. (1997) Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448-1456
3. Lagergren et al. (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med 340(11):825-831
4. Walqvist P, et al. (2006) Systematic review: The impact of gastro-oesphgeal reflux disease on work productivity. Aliment Pharmacol Ther 24(2):259-372
5. Dimenas E, et al. (1993) Quality of life in patients with upper gastointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 28:681-87
6. DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100(1):190-200
7. Lundell L (1994) Long-term treatment of gastro-oesophageal reflux disease with omeprazole. Scand J Gastroenterol Suppl 201:74-88
8. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology 112(6):1798-810
9. Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG (2002) Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 97(3):575-83
10. Myrovold HE, Lundell L, Miettinen P, Pedersen SA, Liedman B, Hatlebakk J, Julkunen R, Levander K, Lamm M, Mattson C, et al. (2001) The cost of long-term therapy for gastro-oesophageal reflux disease: a randomized trial comparing omeprazole and open anti-reflux surgery. Gut 49(4):488-94
11. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, et al. (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial. JAMA 285:2331-38
12. Rantanen TK, Salo JA, Sipponen JT (1999) Fatal and life-threatening complications in antireflux surgery: Analysis of 5,502 operations. Br J Surg 86:1573-77
13. Pleslow D, et al. (2004) Endoscopic full-thickness plication for the treatment of GERD: A multicenter trial. Gastrointest Endosc 59(2):163-171
14. Plesklow D, et al. (2005) Endoscopic full-thickness plication for the treatment of GERD: 12-Month follow-up for the North American open-label trial. Gastrointest Endosc 61(6):643-49
15. Rothstein R, et al. (2006) Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized, sham-controlled trial. Gastroenterology 131(3):704-712
16. Plesklow D, et al. (2007) Endoscopic full-thickness plication for the treatment of GERD: Long-term multicenter results. Surg Endosc 21:439-44
17. Valanovich V, Wallance S, Gusz J (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217-24
18. Revicki D, Wood M, Wiklund I, Crawley J (1998) Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 7(1):75-83
19. McHorney CA, Kosinski M, Ware JE Jr (1994) Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. Med Care 32:551-67
20. Chuttani R, Sud R, Sachdev G, Puri R, Kozarek R, Haber G (2003) A novel endoscopic full-thickness plicator for the treatment of GERD: A pilot study. Gastrointest Endosc 58:770-76
21. Haber G, Sakai P, Moura E, Maluf-Filho F, Enns R, Pleskow D, Lembo A (2005) The Plicator procedure for the treatment of GERD: 12-month multicenter study results. Gastrointest Endosc 71(5):AB17
22. Cohen LB, Johnson DA, Ganz RA, Aisenberg J, Deviere J, Foley TR, Haber GB, Peters JH, Lehman GA (2005) Enteryx implantation for GERD: Expanded multicenter trial results and interim post-approval follow-up to 24 months. Gastrointest Endosc 61(6):650-58
23. Chen YK, Raijan I, Ben-Menachem T, Starpoli AA, Liu J, Pazwash H, Weiland S, Shahrier M, Fortajada E, Saltzman JR, Carr-Locke DL (2005) Long-term outcomes of endoluminal gastroplication: A U.S. multicenter trial. Gastrointest Endosc 61(6):659-67
24. Schiefke I, Zabel-Langhennig A, Neumann S, Feisthammel J, Moessner J, Caca K (2005) Long term failure of endoscopic gastroplication (EndoCinch). Gut 54:752-758